Resultats de la cerca - Patrice Rodien

Refinar resultats
  1. 1
    Sex Bias in Differentiated Thyroid Cancer

    Sex Bias in Differentiated Thyroid Cancer per Valentine Suteau, Mathilde Munier, Claire Briet, Patrice Rodien

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid effects of tyrosine kinase inhibitors

    ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid effects of tyrosine kinase inhibitors per F. Illouz, Doreen Braun, Claire Briet, Ulrich Schweizer, Patrice Rodien

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Genetic Immunization Against the Human Thyrotropin Receptor Causes Thyroiditis and Allows Production of Monoclonal Antibodies Recognizing the Native Receptor

    Genetic Immunization Against the Human Thyrotropin Receptor Causes Thyroiditis and Allows Production of Monoclonal Antibodies Recognizing the Native Receptor per Sabine Costagliola, Patrice Rodien, Marie‐Christine Many, Marian Ludgate, Gilbert Vassart

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Tyrosine kinase inhibitors and modifications of thyroid function tests: a review

    Tyrosine kinase inhibitors and modifications of thyroid function tests: a review per F. Illouz, Sandrine Laboureau-Soares, Séverine Dubois, V. Rohmer, Patrice Rodien

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Defective Mitochondrial ATP Synthesis in Oxyphilic Thyroid Tumors

    Defective Mitochondrial ATP Synthesis in Oxyphilic Thyroid Tumors per Frédérique Savagner, Brigitte Franc, Serge Guyétant, Patrice Rodien, Pascal Reynier, Yves Malthièry

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Activation of the cAMP Pathway by the TSH Receptor Involves Switching of the Ectodomain from a Tethered Inverse Agonist to an Agonist

    Activation of the cAMP Pathway by the TSH Receptor Involves Switching of the Ectodomain from a Tethered Inverse Agonist to an Agonist per Virginie Vlaeminck‐Guillem, Su-Chin Ho, Patrice Rodien, Gilbert Vassart, Sabine Costagliola

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Molecular pathology of the FSH receptor: New insights into FSH physiology

    Molecular pathology of the FSH receptor: New insights into FSH physiology per Geri Méduri, Anne Bachelot, Massimiliano Cocca, C Vasseur, Patrice Rodien, F Kuttenn, Philippe Touraine, Micheline Misrahi

    Publicat 2007
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists

    Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists per F. Illouz, Claire Briet, Lucie Cloix, Yannick Le Corre, Nathalie Baize, T. Urban, Ludovic Martin, Patrice Rodien

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Familial Gestational Hyperthyroidism Caused by a Mutant Thyrotropin Receptor Hypersensitive to Human Chorionic Gonadotropin

    Familial Gestational Hyperthyroidism Caused by a Mutant Thyrotropin Receptor Hypersensitive to Human Chorionic Gonadotropin per Patrice Rodien, C Brémont, Marie-Laure Raffin Sanson, Jasmine Parma, Jacqueline Van Sande, Sabine Costagliola, Jean-Pierre Luton, Gilbert Vassart, Laurence Duprez

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Efficacy of Sunitinib in Advanced Medullary Thyroid Carcinoma: Intermediate Results of Phase II THYSU

    Efficacy of Sunitinib in Advanced Medullary Thyroid Carcinoma: Intermediate Results of Phase II THYSU per Alain Ravaud, Christelle de la Fouchardière, Julien Asselineau, Jean‐Pierre Delord, Christine Do Cao, Patricia Niccoli, Patrice Rodien, Marc Klein, Bogdan Catargi

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  11. 11
    Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and G<sub>s</sub>α Genes as a Cause of Toxic Thyroid Adenomas<sup>1</sup>

    Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and G<sub>s</sub>α Genes as a Cause of Toxic Thyroid Adenomas<sup>1</sup> per Jasmine Parma, Laurence Duprez, Jacqueline Van Sande, J Hermans, P Rocmans, Guy Van Vliet, Sabine Costagliola, Patrice Rodien, Jacques E. Dumont, Gilbert Vassart

    Publicat 1997
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action

    2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action per Luca Persani, Patrice Rodien, Carla Moran, W. Edward Visser, Stefan Groeneweg, Robin P. Peeters, Samuel Refetoff, Mark Gurnell, Paolo Beck‐Peccoz, Krishna Chatterjee

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Modulation of Ligand Selectivity Associated with Activation of the Transmembrane Region of the Human Follitropin Receptor

    Modulation of Ligand Selectivity Associated with Activation of the Transmembrane Region of the Human Follitropin Receptor per Lucia Montanelli, Joost J. J. van Durme, Guillaume Smits, Marco Bonomi, Patrice Rodien, Eric J. Devor, Kristin A. Moffat-Wilson, Leonardo Pardo, Gilbert Vassart, Sabine Costagliola

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    A Novel Mutation in THRA Gene Associated With an Atypical Phenotype of Resistance to Thyroid Hormone

    A Novel Mutation in THRA Gene Associated With an Atypical Phenotype of Resistance to Thyroid Hormone per Stéphanie Espiard, Frédérique Savagner, Frédéric Flamant, Virginie Vlaeminck‐Guillem, Romain Guyot, Mathilde Munier, Michèle d’Herbomez, William Bourguet, Graziella Pinto, Christian Rosé, Patrice Rodien, Jean-Louis Wémeau

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    A Chorionic Gonadotropin–Sensitive Mutation in the Follicle-Stimulating Hormone Receptor as a Cause of Familial Gestational Spontaneous Ovarian Hyperstimulation Syndrome

    A Chorionic Gonadotropin–Sensitive Mutation in the Follicle-Stimulating Hormone Receptor as a Cause of Familial Gestational Spontaneous Ovarian Hyperstimulation Syndrome per Claudine Vasseur, Patrice Rodien, Isabelle Beau, Agnès Desroches, C. Gérard, L. de Poncheville, Stéphanie Chaplot, Frédérique Savagner, Anne Croué, E Mathieu, Najiba Lahlou, Philippe Descamps, Micheline Misrahi

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d'Etude des Tumeurs Endocrines

    Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d'Etude des Tumeurs E... per V. Rohmer, G. Vidal-Trécan, A. Bourdelot, Patricia Niccoli, A. Murat, Jean-Louis Wémeau, Françoise Borson‐Chazot, Claire Schvartz, Antoine Tabarin, Olivier Chabre, G Chabrier, P. Caron, Patrice Rodien, M. Schlumberger, E. Baudin

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    NATURAL HISTORY OF MEDULLARY THYROID CARCINOMA IN MEN-2 PATIENTS CARRYING A VARIANT AT CODON 804 IN THE RET PROTO-ONCOGENE: A STUDY BY THE FRENCH NEUROENDOCRINE TUMOR GROUP (GTE)

    NATURAL HISTORY OF MEDULLARY THYROID CARCINOMA IN MEN-2 PATIENTS CARRYING A VARIANT AT CODON 804 IN THE RET PROTO-ONCOGENE: A STUDY BY THE FRENCH NEUROENDOCRINE TUMOR GROUP (GTE) per Valentine Suteau, M. Lebeault, Martin Schlumberger, Mohamed Zalzali, Hélène Lasolle, Maëlle Le Bras, G. Chabrier, I. Raingeard, Frédéric Castinetti, Philippe Caron, C. Ghander, Nicolas Chevalier, Delphine Mirebeau-Prunier, V. Rohmer, Patrice Rodien, Claire Briet

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial

    Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial per Gudmundur Johannsson, Ulla Feldt‐Rasmussen, Ida Holme Håkonsson, Henrik Biering, Patrice Rodien, Shigeyuki Tahara, Andrew Toogood, Michael Højby Rasmussen, Lorie A. Kloda, Lorie A. Kloda, Henrik Biering, Wölfram Karges, Alexander Mann, Jens Sandahl Christiansen, Troels Krarup Hansen, Marianne Andersen, Ulla Feldt‐Rasmussen, Sine Borresen, Patrice Rodien, Françoise Borson‐Chazot, V. Kerlan, Bertrand Cariou, Bruno Vergès, Shigeyuki Tahara, Akira Matsuno, Koji Takano, Tetsuya Tagami, Yutaka Takahashi, Toshikazu Takahashi, Masahiro Yamamoto, Gudmundur Johannsson, Charlotte Höybye, Eva‐Marie Erfurth, William Drake, Claire Higham, Robert F. Murray, Andrew Toogood, Antonia Brooke

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)

    Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA) per Alan L. Ho, Marek Dedecjus, Lori J. Wirth, R. Michael Tuttle, William B. Inabnet, Jan Tennvall, Fernanda Vaisman, Lars Bastholt, Andrew G. Gianoukakis, Patrice Rodien, Ralf Paschke, Rossella Elisei, David Viola, Karen So, Danielle Carroll, Tina Hovey, Bhavana Thakre, James A. Fagin

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer

    Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer per Lori J. Wirth, Marcia S. Brose, Eric J. Sherman, Lisa Licitra, Martin Schlumberger, Steven I. Sherman, Keith C. Bible, Bruce Robinson, Patrice Rodien, Yann Godbert, Christelle de la Fouchardière, Kate Newbold, Christopher M. Nutting, Soamnauth Misir, Ran Xie, A. Almonte, Weifei Ye, Maria E. Cabanillas

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: